The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer
Abstract Paclitaxel combination therapy is the main chemotherapy regimen for endometrial cancer (EC); however, subsequent drug resistance is a bottleneck limiting its widespread clinical application. We found that human insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) was abnormally ele...
Saved in:
| Main Authors: | Yidong Ge, Lili Kong, Yuxuan Li, Zongdong Yu, Fengguang Zhai, Ziqing Zhan, Gun Chen, Shuyan Wang, Haoyun Wang, Yuxuan Wang, Jianan Zhao, Lechen Hu, Jianing Mao, Siyuan Wang, Jiaxin Shi, Mengxiang Zhao, Pengrong Lou, Meng Ye, Xiaofeng Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-025-08065-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer
by: Yidong Ge, et al.
Published: (2025-07-01) -
LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma
by: Yuxuan Li, et al.
Published: (2025-06-01) -
Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
by: Applied Bionics and Biomechanics
Published: (2023-01-01) -
SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
by: Qiwei Jiang, et al.
Published: (2021-08-01) -
IGF2BP3-mediated m6A modification of RASGRF1 promoting joint injury in rheumatoid arthritis
by: Qishun Geng, et al.
Published: (2025-05-01)